Data / Form D filings / Bilayer Therapeutics, Inc.
Bilayer Therapeutics, Inc.: Form D filings
Bilayer Therapeutics, Inc., a biotechnology company in Cambridge, MA, filed 2 Form D notices with the SEC between 2021 and 2023. The latest, on August 4, 2023, reports $300,000 sold of a $1 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- ONE BROADWAY, 14TH FLOOR, Cambridge, MA, 02142
- Phone
- (734) 358-9015
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1859506
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 4, 2023 | New notice | $1,000,000 | $300,000 | $700,000 | 1 | Aug 3, 2023 | sec.gov |
| Apr 29, 2021 | New notice | $3,600,000 | $2,000,000 | $1,600,000 | 2 | Apr 19, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joshua A. Korzenik | Director | |
| Thomas A. Collet | Executive Officer, Director | |
| Robert A. Langer | Director | |
| Huang Giovanni Yen-Chen | Director | |
| David Giovanni Zhu | Director | |
| Carlo Giovanni Traverso | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jul 31, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Bilayer Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.